Compazine /00013302/


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 47.4%
Mantle Cell Lymphoma 36.8%
Nausea 10.5%
Gastrooesophageal Reflux Disease 5.3%
Tremor 50.0%
Weight Decreased 50.0%
Concomitant
Product Used For Unknown Indication 50.5%
Nausea 6.0%
Drug Use For Unknown Indication 5.8%
Pain 5.3%
Constipation 3.7%
Prophylaxis 3.5%
Vomiting 3.3%
Paroxysmal Nocturnal Haemoglobinuria 2.5%
Anxiety 2.3%
Hypertension 2.2%
Pyrexia 2.1%
Plasma Cell Myeloma 2.0%
Non-small Cell Lung Cancer 1.8%
Chronic Lymphocytic Leukaemia 1.6%
Anaphylaxis Prophylaxis 1.4%
Gastrooesophageal Reflux Disease 1.4%
Supplementation Therapy 1.3%
Hypersensitivity 1.2%
Prostate Cancer 1.2%
Diarrhoea 1.0%
Vomiting 31.8%
Weight Decreased 6.8%
Nausea 5.7%
Pyrexia 5.7%
Pain 4.5%
Pericarditis 4.5%
Bone Pain 3.4%
Pneumonia 3.4%
Pulmonary Embolism 3.4%
Rib Fracture 3.4%
Subarachnoid Haemorrhage 3.4%
Transfusion Reaction 3.4%
Urticaria 3.4%
White Blood Cell Count Decreased 3.4%
Cerebrovascular Accident 2.3%
Hypoglycaemia 2.3%
Pain In Jaw 2.3%
Pancreatitis 2.3%
Pancreatitis Acute 2.3%
Rash 2.3%

Drug Data